When subscribers click this link, they’ll be redirected to
https://medcitynews.com/2026/10/shionogi-adds-to-its-rare-disease-strategy-with-2b-intrabio-acquisition/You’re seeing this page because you clicked a link in a preview email. Actions can’t be completed from preview emails, so this page is here for you to confirm that your link is set up correctly.